Edesa Biotech Showcases Innovation at Investor Conference

TipRanksApr 12 04:37

Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference

TORONTO, ON / ACCESSWIRE / April 11, 2024 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory disea

AccesswireApr 11 21:00

Edesa Biotech to Participate in Upcoming Investor Conferences

TORONTO, ON / ACCESSWIRE / April 2, 2024 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseas

AccesswireApr 2 21:00

Edesa Biotech(EDSA.US) 10% Shareholder Buys US$20,000 in Common Stocks

$Edesa Biotech(EDSA.US)$ 10% Shareholder Nijhawan Pardeep purchased 5,000 shares of Common Stocks on Mar 25, 2024 at an average price of $4 for a total value of $20,000. This transaction involves othe

Futu NewsMar 26 07:43

Edesa Biotech Shines at Autoimmune Conference

TipRanksMar 22 12:37

Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Conference

TORONTO, ON / ACCESSWIRE / March 21, 2024 / Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory disea

AccesswireMar 22 04:30